| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,849 |
3,618 |
$671K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,779 |
1,713 |
$156K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,280 |
2,194 |
$138K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
252 |
193 |
$38K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
275 |
234 |
$23K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
268 |
263 |
$20K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
402 |
357 |
$17K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
226 |
201 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
66 |
65 |
$4K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
73 |
72 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
49 |
48 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
75 |
74 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
57 |
54 |
$2K |
| 80061 |
Lipid panel |
27 |
26 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
25 |
25 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
25 |
24 |
$1K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
24 |
24 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
30 |
$1K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$788.53 |
| 3078F |
|
485 |
462 |
$0.72 |
| 1036F |
|
436 |
413 |
$0.56 |
| 3074F |
|
335 |
326 |
$0.17 |
| 4004F |
|
16 |
14 |
$0.09 |
| 4010F |
|
25 |
24 |
$0.03 |
| 3079F |
|
53 |
50 |
$0.03 |
| 3077F |
|
15 |
15 |
$0.02 |
| 3075F |
|
14 |
12 |
$0.00 |